Stockscreener 앱 받기
66.87
2.14%
-1.46
시간 외 거래:
66.87
전일 마감가:
$68.33
열려 있는:
$68.8
하루 거래량:
3.48M
Relative Volume:
1.72
시가총액:
$32.61B
수익:
$10.63B
순이익/손실:
$819.00M
주가수익비율:
40.34
EPS:
1.6577
순현금흐름:
$1.59B
1주 성능:
-0.34%
1개월 성능:
+0.09%
6개월 성능:
-17.46%
1년 성능:
-22.96%
1일 변동 폭
$65.99
$69.00
1주일 범위
$65.99
$69.75
52주 변동 폭
$61.84
$92.55
Alcon Inc Stock (ALC) Company Profile
Compare ALC vs ISRG, BDX, MDLN, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ALC
Alcon Inc
|
66.87 | 33.32B | 10.63B | 819.00M | 1.59B | 1.6577 |
ISRG
Intuitive Surgical Inc
|
427.30 | 153.29B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
156.30 | 42.86B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
43.01 | 36.15B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
219.75 | 31.68B | 5.54B | 1.52B | 1.74B | 10.37 |
Alcon Inc Stock (ALC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-26 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2026-01-30 | 개시 | William Blair | Mkt Perform |
| 2026-01-20 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2026-01-09 | 다운그레이드 | Stifel | Buy → Hold |
| 2025-12-11 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2025-08-21 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2025-05-20 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2025-05-14 | 재확인 | BTIG Research | Buy |
| 2025-03-28 | 재확인 | Needham | Buy |
| 2025-03-25 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2025-01-24 | 재확인 | Needham | Buy |
| 2025-01-10 | 업그레이드 | Redburn Atlantic | Neutral → Buy |
| 2024-12-17 | 재확인 | Needham | Buy |
| 2024-11-12 | 재확인 | Needham | Buy |
| 2024-10-10 | 업그레이드 | Redburn Atlantic | Sell → Neutral |
| 2024-09-10 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-07-15 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2024-05-15 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2024-04-10 | 개시 | Goldman | Buy |
| 2024-03-14 | 개시 | RBC Capital Mkts | Sector Perform |
| 2024-02-06 | 재개 | KeyBanc Capital Markets | Overweight |
| 2024-01-23 | 개시 | Bernstein | Outperform |
| 2023-12-18 | 다운그레이드 | Redburn Atlantic | Neutral → Sell |
| 2023-12-12 | 개시 | Stifel | Buy |
| 2023-12-04 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2023-08-17 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2023-05-30 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-05-10 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2023-03-01 | 업그레이드 | Societe Generale | Sell → Hold |
| 2022-12-22 | 개시 | Mizuho | Buy |
| 2022-11-17 | 다운그레이드 | Societe Generale | Hold → Sell |
| 2022-08-11 | 다운그레이드 | Societe Generale | Buy → Hold |
| 2022-05-13 | 재개 | Credit Suisse | Outperform |
| 2022-05-12 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2022-04-08 | 개시 | Needham | Buy |
| 2022-03-11 | 개시 | BofA Securities | Buy |
| 2022-01-18 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2022-01-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-01 | 개시 | Oppenheimer | Perform |
| 2021-07-14 | 개시 | Deutsche Bank | Buy |
| 2021-05-06 | 업그레이드 | Citigroup | Sell → Neutral |
| 2021-03-22 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2020-11-12 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2020-07-06 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2020-07-06 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2020-06-16 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2020-04-08 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2020-03-26 | 업그레이드 | Argus | Hold → Buy |
| 2020-03-24 | 업그레이드 | Societe Generale | Sell → Hold |
| 2020-03-13 | 업그레이드 | UBS | Neutral → Buy |
| 2020-03-05 | 개시 | Citigroup | Neutral |
| 2020-02-26 | 업그레이드 | Berenberg | Hold → Buy |
| 2020-01-08 | 개시 | Argus | Hold |
| 2019-10-29 | 개시 | Stephens | Equal-Weight |
| 2019-08-21 | 재확인 | BofA/Merrill | Neutral |
| 2019-06-24 | 개시 | SVB Leerink | Mkt Perform |
| 2019-06-14 | 개시 | BTIG Research | Neutral |
| 2019-05-10 | 개시 | Robert W. Baird | Outperform |
| 2019-05-02 | 개시 | Credit Suisse | Outperform |
모두보기
Alcon Inc 주식(ALC)의 최신 뉴스
RXST: Collaboration with Alcon and product innovation offset Q2 headwinds, supporting revised 2026 outlook - TradingView
Alcon, RxSight Begin Co-Developing Presbyopia-Correcting IOLs - Medical Product Outsourcing
DAILIES TOTAL1 from Alcon Inc.daily lenses engineered for all?day comfort - AD HOC NEWS
Stifel reiterates Hold on RxSight stock, $8 target on Alcon deal By Investing.com - Investing.com Canada
Alcon focuses on eye care growth as a global leader - AD HOC NEWS
Alcon spends up to $200m to co-develop customisable cataract lenses with RxSight - Yahoo Finance
Alcon focuses on eye care growth as demand for vision treatments rises - AD HOC NEWS
Alcon focuses on eye care growth as investors watch long-term trends - AD HOC NEWS
Alcon, RxSight Partner to Develop Adjustable Presbyopia-Correcting IOLs - VisionMonday.com
Alcon Silver Announces Shareholder Approval of Arrangement - Yahoo! Finance Canada
Alcon (ALC) Partners with RxSight for Innovative Lens Developmen - GuruFocus
Alcon, RxSight partner on adjustable lens technology By Investing.com - Investing.com South Africa
ALCON AGRXSIGHT TO RECEIVE $60 MLN UPFRONT PAYMENT UNDER AGREEMENT - Moomoo
RxSight, Inc. Announces Preliminary Second Quarter Financial Results and Product Pipeline Updates Following Strategic Collaboration Agreement - The Manila Times
Alcon and RxSight team up to develop light-adjustable cataract lenses - StreetInsider
Alcon and RxSight team up on adjustable lenses after cataract surgery - Stock Titan
Alcon focuses on eye care growth as investors watch long-term strategy - AD HOC NEWS
Price to sales forward of Alcon AG – SIX:ALC - TradingView
Alcon stock tracks its core eye care business. Investors await fresh cues. - AD HOC NEWS
Alcon Inc. (ALC) Stock Analysis: Eyeing A 26% Upside With Solid Buy Ratings - DirectorsTalk Interviews
Alcon focuses on ophthalmic growth as investor interest builds - AD HOC NEWS
Alcon stock holds its footing. Focus turns to the eye-care model. - AD HOC NEWS
Alcon Inc (ALC) Stock Up 4.2% and Still Undervalued -- GF Score: 71/100 - GuruFocus
SYSTANE Ultra from Alcon Inc.Dry eye relief built for digital days - AD HOC NEWS
Alcon Inc focuses on eye-care growth as global demand for vision treatment expands - AD HOC NEWS
DAILIES TOTAL1 contact lenses from Alcon Inc.daily disposables built for long screen days - AD HOC NEWS
Enterprise value to revenue forward of Alcon AG – VIE:ALC - TradingView
Total30 contact lenses from Alcon Inc.monthly comfort with water gradient tech - AD HOC NEWS
ALCAlcon Inc Latest SEC Filings - Finviz
Alcon consensus holds steady, shares in focus on SIX Swiss Exchange - AD HOC NEWS
Systane class action claims eye drops falsely advertised as preservative-free - Class Action Lawsuits
MiniMed adds Alcon CEO and Medtronic executive to board By Investing.com - Investing.com Canada
Press Release: MiniMed Appoints Alcon CEO David Endicott and Linnea Burman to Its Board of Directors - Moomoo
Alcon opens the week with a full earnings calendar, shares steady ahead of next update - AD HOC NEWS
Top Intraocular Lens Market Companies Driving Innovation - SNS Insider
Alcon Inc. (ALC) Stock Analysis: A Healthcare Giant With A 29.68% Upside Potential - DirectorsTalk Interviews
Alcon highlights surgical portfolio ahead of Q2, shares trade steadily on SIX - AD HOC NEWS
Alcon adjusts capital structure, shares supported by steady eye care demand - AD HOC NEWS
Lensar Stock Slumps After Hours On Ending Merger Deal With Alcon Over FTC Pushback - Stocktwits
Alcon Shares Fall After Guidance Trim on U.S. Trade Tariff Hit - WSJ
Alcon highlights cataract lens demand, shares on NYSE radar - Ad-hoc-news.de
PRECISION1 daily disposable lenses from Alcon Inc.a quiet push into comfort-first vision - Ad-hoc-news.de
ALC Forecast — Price Target — Prediction for 2027 - TradingView
The Systane ULTRA Lubricant Eye Drops from Alcon Inc.dry-eye relief with long-wear comfort - Ad-hoc-news.de
Alcon strategy in focus, ophthalmic stock attracts long-term investors - Ad-hoc-news.de
The AcrySof IQ Vivity from Alcon Inc.presbyopia lens for everyday sharpness - Ad-hoc-news.de
Alcon updates its strategic outlook, shares in focus for global eye-care investors - Ad-hoc-news.de
Alcon Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.1 Sh Actuals & Estimates (BMFBOVESPA:A2LC34) - TradingView
Alcon refines analyst consensus picture, shares in focus on SIX Swiss Exchange - Ad-hoc-news.de
Alcon, weekly sector review, shares in Swiss trading - Ad-hoc-news.de
Alcon shows steady progress, shares track consistent margins - Ad-hoc-news.de
Alcon Inc (ALC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.62%
0.44%
자본화:
|
볼륨(24시간):